Evidence map›Paper›PMID 38480668›Full record

ArticleMolecular oncology2024

Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells.

Olivier Romito, Aude Lemettre, Aurélie Chantôme, Ophélie Champion, Noémie Couty, Lobna Ouldamer, Nadine Hempel, Mohamed Trebak, Caroline Goupille, Marie Potier-Cartereau

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Olivier RomitoInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Aude LemettreInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Aurélie ChantômeInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Ophélie ChampionInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Noémie CoutyInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Lobna OuldamerInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Nadine HempelUPMC Hillman Cancer Center, Division of Hematology & Oncology, Department of Medicine, University of Pittsburgh, PA, USA.
Mohamed TrebakDepartment of Pharmacology and Chemical Biology, Vascular Medicine Institute, University of Pittsburgh, PA, USA.
Caroline GoupilleInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.
Marie Potier-CartereauInserm UMR 1069, Nutrition Croissance Cancer, Faculté de Médecine, Université de Tours, Tours, France.ORCID 0000-0002-1361-3397
Université de Tours · FRUniversity of Pittsburgh · USUPMC Hillman Cancer Center · US

Funding

Ca2+ Signaling Networks in Health and DiseaseR35HL150778 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TREBAK, MOHAMED · 2020 to 2025
$5.4M
Canceropôle Grand OuestConseil Régional du Centre-Val de LoireInstitut National de la Santé et de la Recherche MédicaleLigue Contre le CancerNHLBI NIH HHS R35 HL150778University of Tours
6 · The paper itself

Abstract

No data are currently available on the functional role of small conductance Ca

Indexed as

Cell MembraneCell MovementOvarian NeoplasmsSmall-Conductance Calcium-Activated Potassium ChannelsCalciumCell Line, TumorDrug Resistance, NeoplasmFemaleHumansLysophospholipidsCalciumKCNN2 protein, humanLysophospholipidsSmall-Conductance Calcium-Activated Potassium Channelscell migrationchemosensitivityhigh‐grade serous ovarian cancerLPASK2 channelTaxol®

Identifiers

PMID38480668
PMCPMC11306528
OpenAlexW4392816465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.